Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Life Science Alliance
|
January 22, 2024
<i>Drosophila</i> MIC10b can polymerize into cristae-shaping filaments
Till Stephan, Stefan Stoldt, Mariam Barbot, et al.
Plos One
|
July 15, 2022
Steep rise in drug use-associated infective endocarditis in West Virginia: Characteristics and healthcare utilization
Ruchi Bhandari, Talia Alexander, Frank H Annie, et al.
Journal of Clinical Medicine
|
June 24, 2022
Sex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter Study
Ruchi Bhandari, Shabnam Tiwari, Talia Alexander, et al.
Obstetrics & Gynecology Science
|
September 3, 2020
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D Kalachand, Ciaran O'Riain, Sinead Toomey, et al.
Pathology, Research and Practice
|
September 17, 2025
FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinoma
Mark Bates, Jason McGrath, Laura Byrne, et al.
Scientific Reports
|
March 6, 2023
Ex vivo expansion of circulating tumour cells (CTCs)
Bashir M Mohamed, Mark P Ward, Mark Bates, et al.
Molecular Cancer
|
April 1, 2021
Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?
Mark P Ward, Laura E Kane, Lucy A Norris, et al.
Cell Death & Disease
|
October 20, 2017
CD10<sup>-</sup>/ALDH<sup>-</sup> cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy
Brendan Ffrench, Claudia Gasch, Karsten Hokamp, et al.
Frontiers in Cell and Developmental Biology
|
December 25, 2023
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy
Tanya E Kelly, Cathy L Spillane, Mark P Ward, et al.
Pathology, Research and Practice
|
December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer
Mark Bates, Dorinda Mullen, Eimear Lee, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Life Science Alliance
|
January 22, 2024
<i>Drosophila</i> MIC10b can polymerize into cristae-shaping filaments
Till Stephan, Stefan Stoldt, Mariam Barbot, et al.
Plos One
|
July 15, 2022
Steep rise in drug use-associated infective endocarditis in West Virginia: Characteristics and healthcare utilization
Ruchi Bhandari, Talia Alexander, Frank H Annie, et al.
Journal of Clinical Medicine
|
June 24, 2022
Sex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter Study
Ruchi Bhandari, Shabnam Tiwari, Talia Alexander, et al.
Obstetrics & Gynecology Science
|
September 3, 2020
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D Kalachand, Ciaran O'Riain, Sinead Toomey, et al.
Pathology, Research and Practice
|
September 17, 2025
FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinoma
Mark Bates, Jason McGrath, Laura Byrne, et al.
Scientific Reports
|
March 6, 2023
Ex vivo expansion of circulating tumour cells (CTCs)
Bashir M Mohamed, Mark P Ward, Mark Bates, et al.
Molecular Cancer
|
April 1, 2021
Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?
Mark P Ward, Laura E Kane, Lucy A Norris, et al.
Cell Death & Disease
|
October 20, 2017
CD10<sup>-</sup>/ALDH<sup>-</sup> cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy
Brendan Ffrench, Claudia Gasch, Karsten Hokamp, et al.
Frontiers in Cell and Developmental Biology
|
December 25, 2023
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy
Tanya E Kelly, Cathy L Spillane, Mark P Ward, et al.
Pathology, Research and Practice
|
December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer
Mark Bates, Dorinda Mullen, Eimear Lee, et al.
Page
of 7